Agios Pharmaceuticals, Inc. (AGIO)
27.35
+0.50
(+1.86%)
USD |
NASDAQ |
Dec 10, 12:33
Agios Pharmaceuticals Profit Margin (Quarterly): -803.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 21.32% |
| Fulcrum Therapeutics, Inc. | -- |
| Moderna, Inc. | -19.68% |
| EyePoint Pharmaceuticals, Inc. | -6.18K% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.53% |
| Return on Assets | -25.50% |
| Return on Invested Capital | -26.57% |
| Gross Profit Margin (Quarterly) | 76.30% |
| Operating Margin (Quarterly) | -907.4% |
| Return on Net Operating Assets | -475.5% |